Rapid dosage titration of levetiracetam in children

Pharmacotherapy

Volumn 28, Issue 3, 2008, Pages 393-396

  Vaisleib, Inna I ^a   Neft, Robyn A ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Adverse drug effects; Epilepsy; Levetiracetam; Seizures

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETIRACETAM; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADOLESCENT HEALTH; ARTICLE; BEHAVIOR DISORDER; BENIGN CHILDHOOD EPILEPSY; CHILD; CHILD HEALTH; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EVENING DOSAGE; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; MORNING DOSAGE; NEUTROPENIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; SEIZURE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DEMOGRAPHY; DRUG ADMINISTRATION SCHEDULE; EPILEPSY; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; PIRACETAM; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 40149103122     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.3.393     Document Type: Article

References (8)

1. Glauser TA, Ayala R, Elterman RD, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006;66:1654-60.
2. UCB Pharma, Inc. Keppra (levetiracetam) package insert. Smyrna, GA; 2005.
3. Abou-Khalil B. Benefit-risk assessment of levetiracetam in the treatment of partial seizures. Drug Saf 2005;28:871-90.
4. White JR, Walczak TS, Leppik IE, et al. Discontinuation of levetiracetam because of behavioral side effects: a case-control study. Neurology 2003;61:1218-21.
5. Betts T, Waegemans T, Crawford P. A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy Seizure 2000;9:80-8.
6. Bryant AE. Rapid titration of levetiracetam is effective and well tolerated [abstract]. Epilepsia 2002;43(suppl 7):217.
7. Lagae L, Buyse G, Deconinck A, Ceulemans B. Effect of levetiracetam in refractory childhood epilepsy syndromes. Eur J Paediatr Neurol 2003;7:123-8.
8. Coppola G, Mangano S, Tortorella G, et al. Levetiracetam during 1-year follow-up in children, adolescents, and young adults with refractory epilepsy. Epilepsy Res 2004;59:35-42.